Foundation Medicine-B (02616): The long-term survival data of Sutrealumab GEMSTONE-302 reappeared in "The Lancet Oncology"

Zh tng cijng APP xn, jsh yoy-B (02616) fb gnggo, shgl dnkng linh hn b hulio yxin zhlng zhn fi zhn zhung IV q fi xio xbo ci (NSCLC) (fi zh i jnqin xng) de III q lnjng ynji (GEMSTONE-302) chngq shngcn shj, fbio y guj dngj zngh x huxu qkn Li y do zhng zh xu (The Lancet Oncology) J gi ynji de w jnzhn shngcn q (PFS) zuzhng fnx h zng shngcn q (OS) q zhng fnx jigu xin hu fbio y Li y do zhngzh xu (2022 nin) y Zrn i zhng (Nature Cancer, 2023 nin) hu, c c pngk chngq shngcn shj znd dngd tng y dngj qkn, shxinle shgl dnkng huyn zhngj lin de wnzhng gujin, jn yb chnxin q lnjng jizh, bng gndle q zi zhnggu j uzhu dq wnc NSCLC zhlio lngy de biozhn yxin zhlng dwi.